Navigation Links
KePRO Names Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director

Dr. Chesky will lead clinical efforts of Pennsylvania-based contracts

HARRISBURG, Pa., Feb. 26 /PRNewswire/ -- KePRO, a respected and rapidly expanding national medical management firm, named Stuart B. Chesky, DO, JD, as Pennsylvania Medical Director. Dr. Chesky, who replaces retiring medical director, Frank Castrina, MD, will oversee all clinical aspects of operations being performed in KePRO's Harrisburg headquarters.

"Dr. Chesky's combined medical and legal expertise lend themselves well to contract activities taking place in Pennsylvania," said Alice Stollenwerk Petrulis, MD, FACP, KePRO's Chief Medical Officer. "KePRO's medical risk management work with the Health Resources and Services Administration (HRSA) is among the many contracts that will benefit from Dr. Chesky's professional training and acumen."

Dr. Chesky will lead all medical aspects relating to the peer review process, utilization review activities, risk management, credentialing, and other projects originating from the Harrisburg office. He will also play a key role in promoting the company's business development, physician recruitment, and strategic planning initiatives.

"I look forward to providing the clinical leadership necessary to assist KePRO's current and future contracts," said Dr. Chesky. "My obstetrics and legal background complements the medical malpractice review and risk and claims management recommendation activities that KePRO performs for HRSA's federally deemed health centers and free clinics. My expertise also aligns nicely with the organization's future contracting goals."

His varied experience includes medical malpractice culpability assessment and case review, providing expert medical testimony, and consulting for workers' compensation cases. Dr. Chesky has published several papers, including "VBAC (Vaginal Birth After Cesarean Section), a Medical Controversy," which appeared in the Medical Trial Technique Quarterly; and "Herpes Simplex type II," appearing in the Journal of Osteopathic Physicians & Surgeons of California.

Among his numerous accomplishments, Dr. Chesky is a past president of the Osteopathic Physicians and Surgeons of California. He has held nine teaching positions, including Clinical Associate Professor, Obstetrics and Gynecology at Ohio University; Chairman of the Department and full professor of Obstetrics and Gynecology at the College of Osteopathic Medicine of the Pacific of Western University of Health Sciences; and held an academic appointment in Obstetrics and Gynecology at the University of California at Irvine.

Dr. Chesky received his Doctor of Osteopathic Medicine degree from Midwestern University/ Chicago College of Osteopathic Medicine; his specialty is Obstetrical and Gynecological Surgery. He is licensed to practice medicine in multiple states, including Ohio.

He received his Juris Doctorate degree from the Ohio Northern University College of Law. His Bachelor of Science degree is from Roosevelt University.

Professional affiliations include, fellow of the American College of Legal Medicine, distinguished fellow of the American College of Osteopathic Obstetricians and Gynecologists, the American Osteopathic Association, and the Association of Trial Lawyers of America.

About KePRO

KePRO and its family of companies offer utilization, case, and disease management solutions to more than four million lives in the United States in both the public and private sectors. By transforming data into action, KePRO's evidence-based approach to patient-centric care optimizes individual health outcomes while delivering financial results.

Headquartered in Pennsylvania, KePRO also has offices in Florida, Kentucky, Maryland, Ohio, Tennessee, and Virginia. KePRO is URAC health utilization management and case management accredited. For more information about KePRO, visit

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sharon McCudden Named KePRO Director of Business Process Improvement & Compliance
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Mediware Names Thomas K. Mann Chief Executive Officer
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
6. Patient Safety Authority Board of Directors Names Infection Advisory Panel
7. Hooper Holmes Names Chris Behling President of Health & Wellness Division
8. MDMA Names New Director of Federal Affairs
9. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
10. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
11. MAKO Surgical Corp. Names Frederic H. Moll, M.D. to Board of Directors
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: